Briobacept
Briobacept is a biological drug designed to modulate the immune system. It is primarily used in the treatment of autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. Briobacept functions as a fusion protein that targets specific pathways involved in immune response regulation.
Mechanism of Action[edit | edit source]
Briobacept is a recombinant fusion protein that combines the extracellular domain of a human protein with the Fc portion of human IgG1. This design allows Briobacept to bind to specific receptors on immune cells, thereby inhibiting their activation and proliferation. The primary target of Briobacept is the CD28 co-stimulatory pathway, which is crucial for T-cell activation. By blocking this pathway, Briobacept reduces the activity of T-cells, leading to decreased inflammation and tissue damage in autoimmune conditions.
Clinical Applications[edit | edit source]
Briobacept is used in the management of several autoimmune diseases, including:
In clinical trials, Briobacept has shown efficacy in reducing symptoms and slowing disease progression in these conditions. It is typically administered via subcutaneous injection, with dosing regimens varying based on the specific condition and patient response.
Side Effects[edit | edit source]
Common side effects of Briobacept include:
- Injection site reactions
- Upper respiratory tract infections
- Headache
Serious side effects, although rare, may include:
- Increased risk of infections
- Hypersensitivity reactions
- Potential for malignancies
Patients receiving Briobacept should be monitored for signs of infection and other adverse effects.
Research and Development[edit | edit source]
Briobacept is currently under investigation for its potential use in other autoimmune and inflammatory conditions. Ongoing studies are exploring its efficacy and safety in diseases such as multiple sclerosis and inflammatory bowel disease.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
